(Q34802216)

4 August 2017

1 reference

title

Vasopressin as a target for antidepressant development: an assessment of the available evidence (English)

1 reference

4 August 2017

0 references

2

Timothy G Dinan

1 reference

4 August 2017

Lucinda V Scott

1

1 reference

4 August 2017

language of work or name

1 reference

1 November 2002

1 reference

Journal of Affective Disorders

4 August 2017

published in

1 reference

4 August 2017

volume

72

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

113-124

1 reference

Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Corticotropin-releasing factor receptors: distribution and regulation in brain, pituitary, and peripheral tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: a marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Pharmacology of oxytocin and vasopressin receptors in the central and peripheral nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Vasopressin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Glucocorticoid and mineralocorticoid receptor mRNA expression in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Repeated Stress-Induced Activation of Corticotropin-Releasing Factor Neurons Enhances Vasopressin Stores and Colocalization with Corticotropin-Releasing Factor in the Median Eminence of Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Central nervous system effects of the neurohypophyseal hormones and related peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Glucocorticoids and the genesis of depressive illness. A psychobiological model

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Stimulation of the pituitary-adrenal axis with a low dose [Arg8]-vasopressin in depressed patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Cerebrospinal fluid vasopressin--changes in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Vasopressin in affective illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Effects of 1-desamo-8-D-arginine vasopressin on behaviour and cognition in primary affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

The diurnal variation of urinary and plasma 17-hydroxy-corticosteroid (17-OHCS) levels and the plasma 17-OHCS response to lysine-8-vasopressin in depressive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

A cholinergic-adrenergic hypothesis of mania and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Distinct classes of corticotropes mediate corticotropin-releasing hormone- and arginine vasopressin-stimulated adrenocorticotropin release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Consistent reduction of ACTH responses to stimulation with CRH, vasopressin and hypoglycaemia in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Corticosteroid Inhibition of ACTH Secretion*

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Glucocorticoid receptor in magnocellular neurosecretory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Involvement of Vasopressin V 1 and V 2 -Receptors in Histamine and Stress-Induced Secretion of ACTH and β-Endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Cortisol response to vasopressin in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Pituitary size in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Modulation of basal and corticotropin-releasing factor-stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Role of corticotrophin releasing hormone 41 in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Extrapituitary expression of the rat V1b vasopressin receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Vasopressin and corticotropin-releasing hormone gene responses to novel stress in rats adapted to repeated restraint

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Cortisol and adrenocorticotropin response to desmopressin in women with Cushing's disease compared with depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Stimulation of the pituitary-adrenal axis with arginine vasopressin in patients with depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Vasopressin, major depression, and hypothalamic-pituitary-adrenocortical desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Adrenal gland enlargement in major depression. A computed tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Neurohemal contact in the internal zone of the rabbit median eminence.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Pathways to the secretion of adrenocorticotropin: a view from the portal*.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Regulation of pituitary vasopressin V1b receptor mRNA during stress in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Terminals of reserpine-sensitive vasopressin-neurophysin neurons in the external layer of the rat median eminence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Regulation of Vasopressin Release by Neurotransmitters, Neuropeptides and Osmotic Stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

The corticotropin-releasing factor test in the differential diagnosis of Cushing's syndrome: a comparison with the lysine-vasopressin test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Plasma levels of arginine vasopressin elevated in patients with major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Neuropsychological performance and plasma cortisol, arginine vasopressin and oxytocin in patients with major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Plasma arginine vasopressin and motor activity in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Weak 24-h periodicity of body temperature and increased plasma vasopressin in melancholic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Treatment of depression with antiglucocorticoid drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Antiglucocorticoid treatment of depression: double-blind ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Modulation of CRF-R1 mRNA in rat anterior pituitary by dexamethasone: correlation with POMC mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900026-5

7 January 2021

10.1016/S0165-0327(02)00026-5

Identifiers

DOI

1 reference

4 August 2017

1 reference